Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast

References

• Hamperl H. The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors. Curr Top Pathol. 1970;53:161–220. PMID: 4323195.
   Google Scholar
• Tan PH, Ellis IO. Myoepithelial and epithelial-myoepithelial, mesenchymal and fibroepithelial breast lesions: updates from the WHO classification of tumours of the breast 2012. J Clin Pathol. 2013;66:465–470.
   PubMed Web of Science ®Google Scholar
• Lubin D, Toorens E, Zhang PJ, et al. Adenomyoepitheliomas of the breast frequently harbor recurrent hotspot mutations in PIK3-AKT pathway-related genes and a subset show genetic similarity to salivary gland epithelial-myoepithelial carcinoma. Am J Surg Pathol. 2019;43:1005–1013.
   PubMed Web of Science ®Google Scholar
• Baraban E, Zhang PJ, Jaffer S, et al. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma. Histopathology. 2018;73:897–903.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Qu X, Zhang ZT, et al. Lessons from managing the breast malignant adenomyoepithelioma and the discussion on treatment strategy. World J Oncol. 2017;8:126–131.
   PubMedGoogle Scholar
• Moritz AW, Wiedenhoefer JF, Profit AP, et al. Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma (malignant adenomyoepithelioma) with associated breast malignancies: a case series emphasizing histologic, radiologic, and clinical correlation. Breast. 2016;29:132–139.
   PubMed Web of Science ®Google Scholar
• Curvello R, Alves D, Abud HE, et al. A thermo-responsive collagen-nanocellulose hydrogel for the growth of intestinal organoids. Mater Sci Eng C Mater Biol Appl. 2021;124:112051.
   PubMed Web of Science ®Google Scholar
• Carroll JA, Foliaki ST, Haigh CL. A 3D cell culture approach for studying neuroinflammation. J Neurosci Methods. 2021;358:109201.
   PubMed Web of Science ®Google Scholar
• Maru Y, Tanaka N, Ebisawa K, et al. Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma. Cancer Sci. 2019;110:2992–3005.
   PubMed Web of Science ®Google Scholar
• van de Wetering M, Francies HE, Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161:933–945.
   PubMed Web of Science ®Google Scholar
• Kim M, Mun H, Sung CO, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10:3991.
   PubMed Web of Science ®Google Scholar
• Nuciforo S, Fofana I, Matter MS, et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 2018;24:1363–1376.
   PubMed Web of Science ®Google Scholar
• Wensink E, Bond M, Kucukkose E, et al. A review of the sensitivity of metastatic colorectal cancer patients with deficient mismatch repair to standard-of-care chemotherapy and monoclonal antibodies, with recommendations for future research. Cancer Treat Rev. 2021;95:102174.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Karthaus WR, Lee YS, et al. Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer. Cancer Cell. 2020;38:279–296 e279.
   PubMed Web of Science ®Google Scholar
• Lee SH, Hu W, Matulay JT, et al. Drug response in patient-derived organoid models of bladder cancer. Cell. 2018;173:515–528 e517.
   PubMed Web of Science ®Google Scholar
• Seino T, Kawasaki S, Shimokawa M, et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell. 2018;22:454–467 e456.
   PubMed Web of Science ®Google Scholar
• Sachs N, de Ligt J, Kopper O, et al. Biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172:373–386 e310.
   PubMed Web of Science ®Google Scholar
• Yang L, Tian YH, Leong WS, et al. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro. Breast Cancer Res. 2018;20:113–126.
   PubMed Web of Science ®Google Scholar
• Chen S, Wang H, Li Z, et al. Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription. Br J Cancer. 2018;119:182–192.
   PubMed Web of Science ®Google Scholar
• Du J, Shao Y, Hu Y, et al. Multifunctional liposomes enable active targeting and twinfilin 1 silencing to reverse paclitaxel resistance in brain metastatic breast cancer. ACS Appl Mater Interfaces. 2021;13:23396–23409.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects. J Gastrointest Oncol. 2021;12:S231–S239.
   PubMed Web of Science ®Google Scholar
• Sato Y, Fukuda N, Fujiwara YU, et al. Efficacy of paclitaxel-based chemotherapy after progression on nivolumab for head and neck cancer. Vivo. 2021;35:1211–1215.
   PubMed Web of Science ®Google Scholar
• Lari EA, Lari AA, Alsaeed T. Malignant adenomyoepithelioma of the breast: a case report. Int J Surg Case Rep. 2020;72:56–58.
   PubMed Web of Science ®Google Scholar
• Logie N, Hugh J, Paulson K, et al., Radiotherapy in the multidisciplinary management of adenomyoepithelioma of the breast with an axillary lymph node metastasis: a case report and review of the literature, Cureus, 9 (2017) e1380.
   Google Scholar
• Hayes MM. Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. J Clin Pathol. 2011;64:477–484.
   PubMed Web of Science ®Google Scholar
• Wang H, Brown PC, Chow ECY, et al. 3D cell culture models: drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci. 2021. DOI:10.1111/cts.13066
   Web of Science ®Google Scholar
• Shankaran A, Prasad K, Chaudhari S, et al. Advances in development and application of human organoids. 3 Biotech. 2021;11:257.
   PubMedGoogle Scholar
• Mizuguchi K, Aoki H, Aoyama M, et al. Three-dimensional spheroid culture induces apical-basal polarity and the original characteristics of immortalized human renal proximal tubule epithelial cells. Exp Cell Res. 2021;404:112630.
   PubMed Web of Science ®Google Scholar
• Dame K, Ribeiro AJ. Microengineered systems with iPSC-derived cardiac and hepatic cells to evaluate drug adverse effects. Exp Biol Med (Maywood). 2021;246:317–331.
   PubMed Web of Science ®Google Scholar
• Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18:240–249.
   PubMed Web of Science ®Google Scholar
• Mittal R, Woo FW, Castro CS, et al. Organ-on-chip models: implications in drug discovery and clinical applications. J Cell Physiol. 2019;234:8352–8380.
   PubMed Web of Science ®Google Scholar
• Li Y, Meng Q, Yang M, et al. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B. 2019;9:1113–1144.
   PubMed Web of Science ®Google Scholar
• Weaver RJ, Blomme EA, Chadwick AE, et al. Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. Nat Rev Drug Discov. 2020;19:131–148.
   PubMed Web of Science ®Google Scholar
• Herland A, Maoz BM, Das D, et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat Biomed Eng. 2020;4:421–436.
   PubMed Web of Science ®Google Scholar
• Wang Y, Cheng ZQ, Xu J, et al. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin. Bioengineered. 2021;12:1874–1889.
   PubMed Web of Science ®Google Scholar
• Yao Y, Li XQ, Cheng LH, et al. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway. Bioengineered. 2021;12:4032–4043.
   PubMed Web of Science ®Google Scholar